Device / Technology News

RSS

Electromagnetic pulses decrease pain and inflammation associated with osteoarthritis of knee

Electromagnetic pulses significantly decrease pain and inflammation associated with osteoarthritis of the knee, according to Henry Ford Hospital researchers.

7 Mar 2010

Healthy communication between patients and physicians reduces medical errors

National Patient Safety Awareness Week is taking place from March 7th to the 13th. This year’s theme is all about healthy communication between patients and their physicians. The simple theme Let’s Talk: Healthy Conversations for Safer Healthcare is aimed at helping people become more involved in their own health care.

6 Mar 2010

Leadership challenges and best practices in dealing with FDA’s REMS

Three pharmaceutical executives with extensive experience in dealing with the FDA’s Risk Evaluation and Mitigation Strategy (REMS) will share their thoughts and practices at an open industry webinar at 12 noon EST on Wednesday, March 10, sponsored by ParagonRx.

6 Mar 2010

World through the eyes of a person with eye disease

Lighthouse International, the non-profit leader in vision healthcare, research, education and advocacy, launches a new website that features the first customizable, low-vision simulator that shows how a person with an eye disease sees the world. Visitors can choose a video from YouTube and select a filter that simulates retinitis pigmentosa, macular degeneration, glaucoma or diabetic retinopathy.

6 Mar 2010

Endoscopic and surgical treatment of GV bleeding: MDCTPV could provide valuable references

Gastric varices (GV) are an important complication of portal hypertension. As an almost atraumatic method, computed tomography (CT) angiography has been used widely to show the portal vein system. However, the collateral circulation of GV in different locations has been reported only rarely.

6 Mar 2010

MedFlash sponsors Darryl Strawberry event to increase awareness about autism and MedFlash PHM

Connectyx Technologies Holdings Group Inc. is pleased to announce that the Company's MedFlash® will be the sole sponsor of the Darryl Strawberry event being held at the New York Islanders game tomorrow, Saturday March 6, 2010 at Nassau Veterans Memorial Coliseum. The Nassau Coliseum seats 16,234 and welcomes over 550,000 people per season for Islander games.

6 Mar 2010

FAA's Public Access Defibrillation Program: Emergency University and HeartSine Technologies support

The Federal Aviation Administration (FAA) has announced its selection of Emergency University and HeartSine Technologies to provide nationwide Automated External Defibrillators (AEDs) and program management for ERT members.

6 Mar 2010

Differentiation of cirrhosis from inflammation in patients with ALD: Novel bedside criteria identified

Alcoholic liver disease (ALD) is the most common cause of liver cirrhosis in the Western world. Liver biopsy is currently considered the gold standard for assessing hepatic fibrosis or cirrhosis in these patients. However, it is an invasive procedure, with rare but potentially life-threatening complications and its accuracy is limited due to sampling error. Transient elastography (FibroScan-, FS) is a novel rapid and noninvasive method to assess liver fibrosis via measurement of liver stiffness (LS).

6 Mar 2010

Retractable Technologies v. OMI litigation: Court delivers final judgment and permanent injunction

Retractable Technologies, Inc., a leading maker of safety needle devices, announced that a final judgment and permanent injunction were entered March 4, 2010 in the litigation of Retractable Technologies, Inc. v. OMI (Occupational & Medical Innovations Limited, an Australian company).

6 Mar 2010

ILS selects Provantis for fully automating toxicology data acquisition, analysis and reporting processes

Instem, a leading provider of early drug development software solutions, announced today that Integrated Laboratory Systems (ILS) has subscribed to Provantis™ Online, enhancing their existing software systems.

6 Mar 2010

MedShape Solutions to launch MORPHIX Shape Memory Suture Anchor device at AAOS 2010

MedShape Solutions announced today that it is pursuing Phase III SBIR awards and has received preferred vendor status at Veterans Health Administration Hospitals and other Federally funded hospitals for its MORPHIX ™ Shape Memory Suture Anchor.

6 Mar 2010

American College of Cardiology and HOS establish strategic partnership

A recently established a strategic partnership between the American College of Cardiology and Health Outcomes Sciences (HOS), signals a paradigm shift in the way healthcare is practiced.

6 Mar 2010

Stentys receives CE Marking for its self-expanding and disconnectable stent

Medical device pioneer Stentys announced today that it has received CE Marking for its self-expanding and disconnectable stent to treat acute coronary syndrome (ACS).

5 Mar 2010

Hypertension: Regular nifedipine administration may lead to development of GERD

Nifedipine, a calcium-channel blocker, was shown to decrease lower esophageal sphincter pressure and increase esophageal acid exposure time, while atenolol, a b1 blocker, was shown to inhibit relaxation of the smooth muscle of the esophagus. However, the influence of these anti-hypertensive drugs on the segment of esophageal body contraction using high-resolution manometry was not fully investigated.

5 Mar 2010

XI to showcase HyGreen hand hygiene system at the Fifth Decennial International Conference

Xhale Innovations announced today that it will showcase its hand hygiene system, HyGreen™, at the Fifth Decennial International Conference on Healthcare-Associated Infections to be held March 18 – 22, 2010. This real-time hand hygiene recording and reminding system is designed to assist healthcare facilities with their infection control programs.

5 Mar 2010

MicroPhage seeks FDA clearance for MRSA/MSSA Blood Culture Test, submits clinical study data

MicroPhage announced that it has submitted human data from a pivotal clinical study of its ‘Microphage MRSA/MSSA Blood Culture Test’ to support a U.S. Food and Drug Administration (FDA) 510(k) premarket notification process. The first of MicroPhage’s instrument-free, rapid tests is based on the Company’s patented Bacteriophage Amplification platform technology. MicroPhage further announced that it has already begun OUS commercial shipments of the test.

5 Mar 2010

Varian launches next generation dissolution apparatus

Varian, Inc. announced today the availability of its next generation dissolution apparatus designed for testing tablets, capsules and other dosage forms. The 708-DS supports a broad set of applications ranging from manual dissolution testing to automated, high-throughput analysis. It provides extensive flexibility to match the needs of individual laboratories, whether in research or testing. Integration with either the new Varian UV or LC Dissolution Systems will save time and reduce the potential for sample handling errors.

5 Mar 2010

Medical identity theft: Nearly 1.5 million Americans have been victims

Medical identity theft is an alarming and often undetected offense affecting today’s consumers, according to a recent survey conducted by The Ponemon Institute and sponsored by ProtectMyID.com™, Experian’s multilayered identity theft detection, protection and fraud resolution product. According to the study, nearly 1.5 million Americans have been victims of medical identity theft. For many, the notion of identity theft is both upsetting and daunting, but few individuals realize the specific severity and potential repercussions of medical identity fraud.

5 Mar 2010

Johnson & Johnson Consumer to introduce CYTOMIMIC Technology at 68th AAD meeting

Building on decades of research into how the body's electrical field affects skin regeneration, scientists at Johnson & Johnson Consumer Companies, Inc., have discovered how to harness the power of bioelectricity to help improve skin rejuvenation. The new innovation, called CYTOMIMIC™ Technology, is a proprietary, patented technology that combines essential minerals to deliver biological levels of electric signals similar to the skin's natural bioelectricity.

5 Mar 2010

HOYA ConBio to introduce DermaSculpt and MedLite C5 lasers at AAD Annual Meeting

HOYA ConBio, a global leader in aesthetic medical lasers, will introduce the DermaSculpt Er:YAG and the MedLite C5 Q-Switched Nd:YAG lasers at the 68th Annual Meeting of the American Academy of Dermatology, March 5-9th at the Miami Convention Center (Booth #819).

5 Mar 2010

Device / Technology News

Electromagnetic pulses decrease pain and inflammation associated with osteoarthritis of knee

Healthy communication between patients and physicians reduces medical errors

Leadership challenges and best practices in dealing with FDA’s REMS

World through the eyes of a person with eye disease

Endoscopic and surgical treatment of GV bleeding: MDCTPV could provide valuable references

MedFlash sponsors Darryl Strawberry event to increase awareness about autism and MedFlash PHM

FAA's Public Access Defibrillation Program: Emergency University and HeartSine Technologies support

Differentiation of cirrhosis from inflammation in patients with ALD: Novel bedside criteria identified

Retractable Technologies v. OMI litigation: Court delivers final judgment and permanent injunction

ILS selects Provantis for fully automating toxicology data acquisition, analysis and reporting processes

MedShape Solutions to launch MORPHIX Shape Memory Suture Anchor device at AAOS 2010

American College of Cardiology and HOS establish strategic partnership

Stentys receives CE Marking for its self-expanding and disconnectable stent

Hypertension: Regular nifedipine administration may lead to development of GERD

XI to showcase HyGreen hand hygiene system at the Fifth Decennial International Conference

MicroPhage seeks FDA clearance for MRSA/MSSA Blood Culture Test, submits clinical study data

Varian launches next generation dissolution apparatus

Medical identity theft: Nearly 1.5 million Americans have been victims

Johnson & Johnson Consumer to introduce CYTOMIMIC Technology at 68th AAD meeting

HOYA ConBio to introduce DermaSculpt and MedLite C5 lasers at AAD Annual Meeting

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News